Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
暂无分享,去创建一个
H. Dienes | H. Pfister | O. Guntinas-Lichius | S. Preuss | J. Klussmann | H. Kasper | H. Stützer | T. Hoffmann | S. Weissenborn | E. Speel | Niklas Reimers
[1] C. Arsov,et al. T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx , 2006, International journal of cancer.
[2] G. Elmberger,et al. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. , 2005, Anticancer research.
[3] D. Rimm,et al. Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis , 2005, Clinical Cancer Research.
[4] Matteo D'Angelo,et al. Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: Use of fuzzy neural networks , 2005, International journal of cancer.
[5] Chen-Yang Shen,et al. Breast cancer risk associated with genotypic polymorphism of the mitosis‐regulating gene Aurora‐A/STK15/BTAK , 2005, International journal of cancer.
[6] S. Franceschi,et al. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas , 2005, International journal of cancer.
[7] A. Carvalho,et al. Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database , 2005, International journal of cancer.
[8] B. Schmidt,et al. Tongue and tonsil carcinoma , 2005, Cancer.
[9] S. Syrjänen. Human papillomavirus (HPV) in head and neck cancer. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[10] S. Franceschi,et al. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.
[11] H. Dienes,et al. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. , 2005, Advances in oto-rhino-laryngology.
[12] H. Modjtahedi. Molecular therapy of head and neck cancer , 2005, Cancer and Metastasis Reviews.
[13] M. Gillison,et al. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.
[14] D. Rimm,et al. Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer , 2004, Clinical Cancer Research.
[15] D. Lowy,et al. A causal role for human papillomavirus in head and neck cancer , 2004, The Lancet.
[16] O. Guntinas-Lichius,et al. HPV-assoziierte Tonsillenkarzinome , 2004, HNO.
[17] L. Turek,et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers , 2004, International journal of cancer.
[18] P. Kantoff,et al. A Phase II Trial of Flavopiridol (NSC #649890) in Patients with Previously Untreated Metastatic Androgen-Independent Prostate Cancer , 2004, Clinical Cancer Research.
[19] B. Rose,et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil , 2004, Head & neck.
[20] R. Biggar,et al. Changing patterns of tonsillar squamous cell carcinoma in the United States , 2000, Cancer Causes & Control.
[21] E. Speel,et al. [HPV-associated tonsillar cancer. An update]. , 2004, HNO.
[22] D. Rimm,et al. Prognostic Significance of p 16 Protein Levels in Oropharyngeal Squamous Cell Cancer , 2004 .
[23] K. Shah,et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] W. Dinjens,et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8 , 2003, International journal of cancer.
[25] B. Rose,et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil , 2003, International journal of cancer.
[26] P. Fuchs,et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? , 2003, Medical Microbiology and Immunology.
[27] E. Vokes,et al. Phase II study of flavopiridol in patients with advanced colorectal cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] L. Turek,et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx , 2003, International journal of cancer.
[29] Iver Petersen,et al. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. , 2003, Cancer research.
[30] P. Schirmacher,et al. Überexpression/Amplifikation des her-2/neu-Protoonkogens in oralen Plattenepithelkarzinomen , 2003, Mund-, Kiefer- und Gesichtschirurgie.
[31] A. Senderowicz. Novel Small Molecule Cyclin-Dependent Kinases Modulators in Human Clinical Trials , 2003, Cancer biology & therapy.
[32] H. Dienes,et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. , 2003, The American journal of pathology.
[33] P. Schirmacher,et al. [Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry]. , 2003, Mund-, Kiefer- und Gesichtschirurgie.
[34] J. Lindholm,et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer , 2002, International journal of cancer.
[35] A. Olshan,et al. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Yinghao Sun,et al. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity , 2002, Cancer Gene Therapy.
[37] J. Mendelsohn. Targeting the epidermal growth factor receptor for cancer therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Wenjun Yang,et al. [Expression of VEGF, EGFR, p16 in lip cancers and oral squamous cell carcinomas and their clinic significance]. , 2002, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.
[39] F. Bosch,et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.
[40] M. Collins,et al. An R201H activating mutation of the GNAS1 (Gsα) gene in a corticotroph pituitary adenoma , 2002, Molecular pathology : MP.
[41] Y. Kwong,et al. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. , 2002, Journal of clinical pathology.
[42] H. Dienes,et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas , 2001, Cancer.
[43] Charles J. Sherr,et al. The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.
[44] G. Tortora,et al. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] J. Laissue,et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.
[46] P. Fuchs,et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.
[47] G. Snow,et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas , 2001, International journal of cancer.
[48] S. Schwartz,et al. Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[49] M. von Knebel Doeberitz,et al. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri , 2001, International journal of cancer.
[50] B. Casto,et al. Somatic INK4a‐ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck , 2001, Molecular carcinogenesis.
[51] R. Todd,et al. Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas. , 2000, Cancer Letters.
[52] P. Fuchs,et al. Papillomavirus DNA in Basal Cell Carcinomas of Immunocompetent Patients: an Accidental Association? , 2000 .
[53] R. Lewensohn,et al. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival , 2000, International journal of cancer.
[54] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[55] P. Fuchs,et al. Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association?TITLE. , 2000, The Journal of investigative dermatology.
[56] R. Sutherland,et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[57] M. Roussel. The INK4 family of cell cycle inhibitors in cancer , 1999, Oncogene.
[58] E. Franco,et al. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract , 1999, Cancer.
[59] H. Tideman. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring , 1999 .
[60] S. Namkoong,et al. Absence ofp15INK4Bandp16INK4AGene Alterations in Primary Cervical Carcinoma Tissues and Cell Lines with Human Papillomavirus Infection , 1998 .
[61] D. Sidransky,et al. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[62] E. Auvinen,et al. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. , 1998, Experimental cell research.
[63] S. Namkoong,et al. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. , 1998, Gynecologic Oncology.
[64] S. Wilczynski,et al. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. , 1998, The American journal of pathology.
[65] J. Bouwes Bavinck,et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. , 1997, The Journal of investigative dermatology.
[66] Dr. J. J. Pindborg,et al. Histological Typing of Cancer and Precancer of the Oral Mucosa , 1997, World Health Organization.
[67] J. Roth,et al. Inhibition of esophageal cancer proliferation by adenovirally mediated delivery of p16INK4. , 1996, Cancer gene therapy.
[68] J. Bartek,et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.
[69] C. Meijer,et al. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. , 1995, British Journal of Cancer.
[70] J. Shay,et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. , 1994, Cancer research.
[71] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[72] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[73] F Demard,et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] F Demard,et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas , 1991, Head & neck.
[75] S. Taylor. Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.